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Edited by Peter BrzezinskiAbstract The bifunctional enzyme UDP-N-acetylglucosamine
2-epimerase/N-acetylmannosamine kinase (GNE) is the key en-
zyme of the biosynthesis of sialic acids, terminal components
of glycoconjugates associated with a variety of cellular pro-
cesses. Two novel isoforms of human GNE, namely GNE2 and
GNE3, which possess extended and deleted N-termini, respec-
tively, were characterized. GNE2 was also found in other species
like apes, rodents, chicken or ﬁsh, whereas GNE3 seems to be
restricted to primates. Both, GNE2 and GNE3, displayed tissue
speciﬁc expression patterns, therefore may contribute to the
complex regulation of sialic acid metabolism.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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kinase1. Introduction
Sialylation of glycoproteins and glycolipids on eukaryotic
cell surfaces plays an important role during development and
regeneration and in the pathogenesis of diseases [1]. By their
high expression on cell surfaces, terminal sialic acids are in-
volved in a variety of cell–cell interactions [2]. They are also
known to be involved in the formation and masking of recog-
nition determinants [3], and the biological stability of glyco-
proteins [4].
N-Acetylneuraminic acid (Neu5Ac) is the biosynthetic pre-
cursor of virtually all of the naturally occurring sialic acids
[5]. In mammals, Neu5Ac and its activated nucleotide sugar
CMP-Neu5Ac are synthesized from UDP-N-acetylglucos-
amine (UDP-GlcNAc) by ﬁve consecutive reactions [6]. The
ﬁrst two steps in this biosynthesis are catalyzed by the bifunc-
tional enzyme UDP-N-acetylglucosamine 2-epimerase/N-acet-
ylmannosamine kinase (UDP-GlcNAc 2-epimerase/ManNAc
kinase; GNE). GNE has been recognized as the key enzyme
in the biosynthetic pathway of sialic acids, as it is rate-limitingAbbreviations: GNE, UDP-N-acetylglucosamine 2-epimerase/N-acet-
ylmannosamine kinase; UDP-GlcNAc, UDP-N-acetylglucosamine;
ManNAc, N-acetylmannosamine; Neu5Ac, N-acetylneuraminic acid;
RT, Reverse transcriptase
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doi:10.1016/j.febslet.2007.06.026for the whole pathway and feedback inhibited by CMP-
Neu5Ac [7]. The biological importance of the enzyme is further
reﬂected in a drastic reduction of cellular sialylation upon loss
of enzyme activity [8]. Furthermore the knockout of the gene
in mice is embryonic lethal at day 8.5 [9]. Two human diseases
are referred to point mutations in the GNE gene. Sialuria is
characterized by a massive production of free Neu5Ac due
to loss of the feedback control of the UDP-GlcNAc 2-epimer-
ase activity [10]. Hereditary inclusion body myopathy is an
autosomal recessive neuromuscular disorder, caused by more
than 40 diﬀerent mutations spreading over both functional do-
mains of GNE [11].
Recently, four diﬀerent mRNA splice variants of human
GNE were described [12]. The original GNE gene [13] is com-
plemented by an additional 90 bp exon, named Al, which is lo-
cated about 20000 bp upstream of exon 1 [12]. The four splice
variants result from alternative splicing of the exons Al, 1 and
2. In this study we analyzed the splice variants for the encoded
GNE proteins, and predicted three diﬀerent isoforms, GNE1,
GNE2 and GNE3. Furthermore, we investigated the tissue dis-
tribution of the splice variants and analyzed non-human spe-
cies for the presence of the protein isoforms.2. Materials and methods
2.1. Tissue speciﬁc reverse transcriptase (RT)-PCR
Commercial QUICK-Clone human placenta cDNA (BD Biosci-
ences; Heidelberg, Germany) was used as a template for cDNA ampli-
ﬁcation of splice variant II and III. PCR Ready First Strand cDNA
panels of human and mouse tissues for splicing pattern analysis were
obtained from BioCat (Heidelberg, Germany). PCR reactions were
performed with 2.5 ng cDNA, 5 U Taq DNA polymerase (Fermentas;
St. Leon-Rot, Germany), 2.5 ll 10· Taq buﬀer, 0.4 mM dNTP, 1 mM
MgCl2, 1 lM forward primer, 1 lM reverse primer, and ﬁlled up to
25 ll with nuclease-free H2O. Thermocycling was done in a Mastercy-
cler EP Gradient S (Eppendorf; Hamburg, Germany) with the pro-
gram: 5 min 95 C; indicated numbers of cycles of 30 s 95 C/30 s
60 C/1 min 72 C. As primers for human cDNA ampliﬁcation were
used: Forward-Primer hGNEl (5 0-ATGGAGAAGAATGGAAA-
TAACCGAAAG-30), Forward-Primer hGNE2 (5 0-AGGGTACA-
GAGCTCGTGCTTCGGG-3 0) and Reverse-Primer hGNE (5 0-
GGCAGCCTGCCAAAAGGATGC-3 0). Note, that Forward-Primer
hGNE2 binds in the non-coding part of exon Al, which is not
displayed in Fig. 1, but in the database entry of the complete cDNA
sequence. For mouse cDNA ampliﬁcation Forward-Primer mGNEl
(5 0-ATGGAGAAGAACGGGAACAACCGAAAGCTCCGG-3 0),
Forward-Primer mGNE2 (5 0-ATGGAAACACACGCGCATCTCC-
3 0) and Reverse-Primer mGNE (5 0-TGACCTCGCCTCCTT-
CAATG-30) were used. The PCR products were separated by agarose
gel electrophoresis and corresponding bands were excised. After gel
extraction with the ‘‘QIAquick Gel Extraction Kit’’ (QIAGEN;blished by Elsevier B.V. All rights reserved.
 Fig. 1. N-terminal sequences of human GNE isoforms. Upper panel, GNE1; middle panel, GNE2; lower panel, GNE3. In each panel upper rows
show amino acid sequences of the N-termini of proteins, lower rows show nucleotide sequences of the open reading frame 5 0-ends of corresponding
cDNAs. Bold amino acids are common for GNE1 and GNE2. Plain amino acids are speciﬁc for GNE2 and GNE3, respectively; GNE2 speciﬁc
amino acids are numbered with negative arabic numerals, GNE3 speciﬁc amino acids are numbered with Latin numerals. Bold nucleotides derive
from exon Al, plain nucleotides derive from exon 2, underlined nucleotides derive from exon 3. Amino acids and nucleotides in italics indicate the C-
termini of the proteins and the 3 0-ends of the open reading frames, respectively.
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TOPO vector (Invitrogen; Karlsruhe, Germany). Then, competent
Escherichia coli TOP10 cells (Invitrogen) were transformed. Finally,
the plasmids were isolated and the cDNA inserts were sequenced.
2.2. DNA sequencing
For the sequencing reaction the ‘‘Thermo Sequenase Primer Cycle
Sequencing’’ Kit (Amersham Bioscience; Buckinghamshire, UK) was
used following the manufacturers instructions. As labeled primers were
used: T7-Forward (IRD 800 5 0-TAATACGACTCACTATAGGG-3 0)
and M13-Reverse (IRD 700 5 0-CAGGAAACAGCTATGACCA-
TGA-3 0). The following PCR thermocycling program was used: 25·(20 s 95 C/20 s 60 C/10 s 72 C). The sequences were obtained by a
LI-COR 4200 dual-dye DNA sequencer (MWG-Biotech; Ebersberg,
Germany).2.3. Bioinformatics
NCBI GenBank searches for genomic and cDNA sequences of di-
verse species were performed using BLAST (http://www.ncbi.nlm.nih.-
gov/BLAST). The UCSC genome server was browsed with the
program Blat (http://genome.ucsc.edu/cgi-bin/hgBlat). Sequence align-
ments were done using MacMolly software (Softgene; Berlin, Ger-
many).
S.O. Reinke, S. Hinderlich / FEBS Letters 581 (2007) 3327–3331 33293. Results and discussion
3.1. Identiﬁcation of human GNE isoform sequences
In order to verify the novel GNE splice variants [12] inde-
pendently, ﬁrst of all we browsed genomic and cDNA dat-
abases. Indeed entries of cDNA sequences of the splice
variants were found, which were either predicted from genomic
sequences or truly isolated from cDNA libraries (data not
shown). Two splice variants encode for the well-known GNE
protein consisting of 722 amino acids [13,14], which was
denominated GNE1. Two other splice variants contain open
reading frames encoding for two GNE proteins with modiﬁed
N-termini, namely GNE2 and GNE3. However, slight discrep-
ancies in the nucleotide sequences of the database entries com-
pared to the data published by Watts et al. [12] were observed,
in particular at the exon–exon transitions. Therefore the 5 0-
endings of the cDNAs encoding for GNE2 and GNE3 were
ampliﬁed from human placenta cDNA and ligated into the
pCR2.1-TOPO vector (data not shown). In both cases
sequencing of the PCR products conﬁrmed the sequences of
the database entries.
The 5 0-sequences of the open reading frames of the cDNAs
derived from the splice variants, and the N-termini of GNE1,
GNE2 and GNE3 are presented in Fig. 1. The complete cDNA
and protein sequences can be found as database entries with
the accession numbers AM697708 and AM697709. Compared
to GNE1, the N-terminus of GNE2 was prolonged by 31 addi-
tional amino acids. The ﬁrst 17 amino acids were encoded by
exon Al, the residual 14 amino acids were encoded by the
nucleotides of exon 2. The lack of exon 2 in the cDNA encod-
ing for GNE3 leads to loss of the ﬁrst 55 amino acids of
GNE1. These amino acids were replaced by 14 new amino
acids encoded by exon Al. Note, that for GNE2 the startTable 1
Sequence homology of GNE1, GNE2 and GNE3 from several species
Species Taxonomy GNE1
Human Homo sapiens 722/722 aa
(100%)
Chimpanzee Pan troglodytes 722/722 aa
(100%)
Rhesus monkey Macaca mulatta 721/722 aa
(99.9%)
Orang utan Pongo pygmaeus 719/722 aa
(99.6%)
Pig Sus scrofa 714/722 aa
(98.9%)
Mouse Mus musculus 711/722 aa
(98.5%)
Rat Rattus norvegicus 710/722 aa
(98.3%)
Hamster Cricetulus griseus 708/722 aa
(98.1%)
Opossum Monodelphis domestica 689/722 aa
(95.4%)
Chicken Gallus gallus 671/722 aa
(92.9%)
Zebraﬁsh Danio rerio 582/725 aa
(80.3%)
Green puﬀerﬁsh Tetraodon nigroviridis 570/725 aa
(78.6%)
Japanese puﬀerﬁsh Takifugu rubripes 552/695 aa
(79.4%)
Sequences were obtained from cDNA and genomic databases. All sequences w
relative numbers of identical amino acids are given. GNE2 N-terminus denocodon is at position 93, but for GNE3 an alternative start
codon at position 83 is used. The N-terminal amino acid
sequences of GNE2 and GNE3 are therefore diﬀerent.
3.2. Analysis of GNE isoforms of non-human species
Having identiﬁed GNE isoforms in humans, we were inter-
ested in knowing whether other species also express mRNAs
encoding for GNE isoforms. We therefore browsed available
genomic and cDNA databases of vertebrates. Proteins homol-
ogous to human GNE1 were detected in all mammals investi-
gated and also in chicken and ﬁsh (Table 1). The amino acid
sequences of GNE1 proteins have similarities higher than
95% among mammals. Chicken GNE1 reveals a similarity of
93% compared to human GNE1, whereas the sequence similar-
ity of GNE1 of zebraﬁsh and puﬀerﬁshes to human GNE1 is
only about 80%. cDNAs encoding for GNE2 were found for
all investigated apes and for mouse, rat and chicken. It is likely
that such cDNAs are also present in the other mammals listed
in Table 1, as sequencing and analysis of their genomes is not
completed. The presence of GNE2 therefore seems to be evo-
lutionary conserved amongst mammals. Furthermore, the exis-
tence of GNE2 in chicken argues for the emergence of GNE2
in a common ancestor. However, there is no evidence for
GNE2 in ﬁshes so far. Consequently GNE2 have occurred
after separation of the mammal/bird ancestor from ﬁshes.
The total amino acid sequence similarities of GNE2 proteins
are within the same high range as for GNE1. However, com-
paring only the additional N-termini of GNE2, the sequence
similarities of mouse, rat and chicken GNE2 compared to hu-
man GNE2 drop to less than 60%. For humans an isolated and
sequenced cDNA encoding for GNE3 was found. This was not
the case for other species. Nevertheless, GNE3-encoding
cDNAs could be predicted from ape genomic data (Table 1).GNE2 GNE2 N-terminus GNE3
753/753 aa 31/31 aa 681/681 aa
(100%) (100%) (100%)
752/753 aa 30/31 aa 680/681 aa
(99.9%) (96.8%) (99.9%)
751/753 aa 30/31 aa 679/681 aa
(99.7%) 96.8% (99.7%)
750/753 aa 31/31 aa 679/681 aa
(99.6%) (100%) (99.7%)
729/753 aa 18/31 aa
(96.8%) (58.1%)
728/753 aa 18/31 aa
(96.7%) (58.1%)
688/754 aa 17/32 aa
(91.2%) (53.1%)
ere compared to the sequences of human GNE isoforms. Absolute and
tes the additional amino acids compared to GNE1.
mGNE1
mGNE2
+
+
+
+
+
+
+
-
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Fig. 3. Tissue distribution of mouse GNE isoforms. cDNAs from a
panel of ﬁve diﬀerent mouse tissues were used as templates for RT-
PCR. Thirty PCR cycles ampliﬁed a 415 bp GNEl-cDNA fragment
(upper panel). Forty PCR cycles ampliﬁed a 508 bp GNE2-cDNA
fragment (lower panel; the prominent lower band in the brain sample
was identiﬁed as syntaxin binding protein 1 by sequencing of the PCR
product).
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other isoforms. Although an exon similar to human exon Al
was found also for mouse, rat and chicken, all these exons lack
the GNE3-speciﬁc start codon (Fig. 1), and no mRNA encod-
ing for GNE3 could be postulated. It is therefore likely, that
GNE3 occurred from a point mutation after separation of pri-
mates from the other mammals, followed by generation of a
separate splice variant.
3.3. Tissue distribution of mRNAs encoding for human and
mouse GNE isoforms
Although GNE activity was detected in almost every mam-
malian tissue investigated so far, gross variations are found in
the expression levels [13,14]. Therefore, RT-PCR of a cDNA
panel including ten diﬀerent human tissues was performed.
Speciﬁc primers distinguishing between the open reading
frames encoding for GNE1, GNE2 and GNE3 were used
(Fig. 2). cDNAs encoding for GNE1 were found in all investi-
gated tissues, including heart with a weak, but signiﬁcant sig-
nal. GNE2-encoding cDNAs were only detected in brain,
kidney, liver, placenta, lung, pancreas and colon. GNE3-
encoding cDNAs, which were ampliﬁed simultaneously in
the same RT-PCR, could only be observed by increased num-
ber of PCR cycles, indicating a lower expression level than
GNE2-encoding cDNAs. However, kidney, liver, placenta
and colon revealed signiﬁcant amounts of GNE3-encoding
cDNAs, suggesting a tissue-speciﬁc role of this isoform. Final-
ly, the presence of mRNAs encoding for mouse GNE1 and
GNE2 (for sequence details use accession number
AM697710) were investigated by RT-PCR with a cDNA panel
of ﬁve tissues (Fig. 3). As found for human tissues, all investi-
gated samples display the presence of GNE1. Brain, colon,
kidney and skeletal muscle samples also possess GNE2-encod-Heart
Brain
Kidney
Liver
Placenta
500 bp
750 bp
500 bp
750 bp
500 bp
750 bp
hGNE1
hGNE2
hGNE3
+
-
-
+
+
-
+
+
+
+
+
+
+
+
+
Fig. 2. Tissue distribution of human GNE isoforms. cDNAs from a panel of
primers were used for ampliﬁcation of GNE1 cDNA (upper panel), and GN
only diﬀer in the number of PCR cycles in order to visualize the GNE3 speciﬁ
larger than 500 bp and therefore does not represent GNE3. For clarity, pre
panels.ing cDNAs. Multi-tissue Northern blot analysis revealed only
one 5.2 kb band for human and one 3.2 kb band for mouse,
respectively (data not shown), in accordance to former studies
[13,15]. Although discrimination of mRNAs with diﬀerences of
less than 100 bases in size, as it is the case for GNE1, GNE2
and GNE3 mRNAs, is tricky in Northern blots, carefully
inspection of the blots gave no evidences for a prominent sec-
ond band. We therefore conclude, that in all investigated tis-
sues there is only one major mRNA, most likely for GNE1,
and the other two can only be visualized by RT-PCR.Lung
Spleen
Pancreas
SkeletalM
uscle
Colon
30 cycles
hGNE1
hGNE3
hGNE2
30 cycles
hGNE3
hGNE2
40 cycles
+
+
-
+
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+
+
+
+
-
-
10 diﬀerent human tissues were used as templates for RT-PCR. Speciﬁc
E2 and GNE3 cDNAs (lower panels). Note, that the two lower panels
c band at 500 bp. In the lowest panel the band for the spleen sample is
sence or absence of the isoform-speciﬁc bands are depicted below the
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zyme catalyzing the ﬁrst two steps of sialic acid biosynthesis,
and should therefore be suﬃcient to maintain the production
of sialic acids in all mammalian tissues, including liver which
is the major organ for biosynthesis of sialylated serum glyco-
proteins [14]. The exclusive role of GNE1 in sialic acid produc-
tion is underlined by the lack of GNE2 mRNA in mouse liver.
The isoform GNE2 therefore cannot be necessary for sialic
acid production. Additionally, mouse skeletal muscle expresses
GNE2 mRNA, which is not the case for human skeletal mus-
cle. This point should also be kept in mind in particular when
mouse models of human diseases caused by GNE mutations,
e.g. hereditary inclusion body myopathy, are generated. Final-
ly, the same conclusions are also true for GNE3, which is re-
stricted to only some tissues. It should therefore taken into
account, that the mRNAs for GNE2 and GNE3 are not trans-
lated to proteins, and potential functions of the mRNAs re-
main speculative. However, preliminary attempts of
recombinant expression of GNE2 and GNE3 result in stable
proteins (S.O.R., unpublished results). If this is also true
in vivo, GNE2 and GNE3 may have a function in ﬁne-tuning
of the sialic acid pathway, which is involved in regulation of
the sialylation of particular glycoconjugates via variation of
the intracellular concentration mainly of CMP-sialic acid
[16]. The extended N-terminus of GNE2, which is linked di-
rectly to the epimerase domain, likely inﬂuences the activity
of this domain. This is underlined by preliminary data of re-
combinant GNE2, which still possesses both enzymatic activi-
ties of GNE. On the other hand, the deletion of the ﬁrst 55
GNEl-amino acids in GNE3 seems to cause a total loss of
the epimerase activity in recombinant GNE3. This is in agree-
ment with a rat GNE deletion mutant lacking the ﬁrst 39 ami-
no acids [17], and the new 14 amino acids of GNE3, encoded
by exon Al, are most likely unable to rescue this eﬀect. Conse-
quently GNE3 would possess only ManNAc kinase activity
in vivo, since this function of GNE only needs an intact kinase
domain [17]. It may then participate in a salvage pathway of
the sialic acid metabolism, converting ManNAc derived by
the action of sialate-pyruvate lyase [6,18]. Another possibility
how GNE2 and GNE3 may regulate GNE function is the for-
mation of mixed oligomers. GNE1 was found to assemble as a
homotetramer [19]. Co-expression of diﬀerent isoforms in one
cell may lead to the formation of heterooligomers of diverse
functions in a tissue speciﬁc manner. Further studies, including
recombinant expression, biochemical characterization and
knock-out experiments, will give more insights into the func-
tional roles of GNE isoforms.
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